Matthew Pollman, MD
Cardiologist, Medical Industry Executive, Entrepreneur
Matthew Pollman, M.D. is a cardiologist and cardiovascular molecular biologist with over ten years of experience leading R&D initiatives in the biotechnology, diagnostics, and medical devices healthcare arenas. He is currently the Chairman of Guided Interventions, LLC, a startup company developing a product to help cardiologists better assess the physiological impact of coronary artery blockages. Prior to this latest venture, Dr. Pollman served as Founder, President and Chief Scientific Officer of CV Ingenuity, an early stage company developing a combination drug/device therapy for the treatment of cardiovascular disease, recently acquired by Covidien. Additionally, he has served as Medical Director, Research and Development, Abbott Vascular serving as principal medical and scientific strategist and advisor for the R&D pipeline and Business Development portfolios; guiding both internal and external technology investments. Prior to Abbott's acquisition of Guidant Corporation, Dr. Pollman directed their New Ventures group, a 30+ member in-house start-up incubator responsible for identifying, exploring and incubating significant new business opportunities. Dr. Pollman received his medical training at the University of California San Francisco, Stanford University and Brigham and Women's Hospital. He has served as a full-time faculty member at Harvard Medical School and Morehouse School of Medicine.
End of main page content.